Attention Investors: Don’t Miss Out on Protecting Your Interests in the AeroVironment Inc. Securities Class Action! Top Global Counsel, Rosen, Urges Action Before October 30th Deadline

Important Deadline Reminder for AeroVironment, Inc. Investors Act Now Before October 30, 2023 NEW YORK, Oct. 21, 2023 (GLOBE NEWSWIRE) — Investors who have purchased securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 29, 2021 and December 7, 2021, are reminded by Rosen Law Firm to take action before the October 30, 2023 lead plaintiff…

Read More

Secure Your Counsel: Important Deadline for Securities Class Action Against UiPath Inc. Encouraged by Top-Ranked Investor Counsel Rosen

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages UiPath, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Overview New York, Oct. 21, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of UiPath, Inc. (NYSE: PATH) between April 21, 2021 and March 30, 2022,…

Read More

Attention Investors: Don’t Miss the Deadline for DFS Securities Fraud Class Action Lawsuit – Kessler Topaz Meltzer & Check, LLP Reminds Investors of Discover Financial Services (DFS) Deadline

DFS Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Discover Financial Services (DFS) of Deadline in Securities Fraud Class Action Lawsuit RADNOR, Pa., Oct. 21, 2023 (GLOBE NEWSWIRE) – The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the…

Read More

Unlocking the Potential: ORIC-114’s Initial Phase 1 Dose Escalation Data in Patients with EGFR and HER2 Exon 20 Mutations

Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Promising Results CNS Activity and Systemic Responses ORIC Pharmaceuticals recently presented exciting preliminary data from the Phase 1 clinical trial of ORIC-114, a promising new treatment for patients with EGFR and HER2 exon 20 mutations. The data…

Read More

Revolutionizing Cancer Detection: Precede Biosciences Presents Groundbreaking Clinical Findings at ESMO 2023 and Nature Medicine Publication

Revolutionizing Cancer Detection: Precede Biosciences Presents Groundbreaking Clinical Findings at ESMO 2023 and Nature Medicine Publication Description: Pivotal findings stem from Precede’s first-in-class platform in collaboration with Dana-Farber Cancer Institute Results underscore the immense potential of the blood-based platform to impact therapeutic and clinical decision-making Published dataset is largest of its kind, with over 1,200…

Read More

Breaking News: Pomerantz Law Firm Takes Action Against Farfetch Limited and its Officers – A Class Action Lawsuit Announcement

Pomerantz Law Firm Announces the Filing of a Class Action Against Farfetch Limited and Certain Officers NEW YORK, Oct. 20, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Farfetch Limited (“Farfetch” or the “Company”) (NYSE: FTCH) and certain officers. The class action, filed in the United States…

Read More

Protect Your Investment: Why Seeking Counsel Before the Deadline is Crucial for KenVue Inc. Investors – Insights from Top-Ranked Investor Counsel Rosen

Protect Your Investment: Why Seeking Counsel Before the Deadline is Crucial for KenVue Inc. Investors – Insights from Top-Ranked Investor Counsel Rosen Introduction Investing in a company like KenVue Inc. can be a rewarding experience, but it is also important to protect your investment by seeking counsel before the deadline. With the help of top-ranked…

Read More

U.S. Global Investors Receives Nasdaq Notice for Late Filing of Form 10-K: What You Need to Know

U.S. Global Investors Receives Expected Nasdaq Notice Regarding Late Filing of Form 10-K San Antonio, TX, Oct. 20, 2023 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) The Notification The Company, a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today announces that it received a standard notification letter…

Read More